Andreas Eger

4.4k total citations · 1 hit paper
31 papers, 3.6k citations indexed

About

Andreas Eger is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Andreas Eger has authored 31 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 17 papers in Oncology and 6 papers in Cell Biology. Recurrent topics in Andreas Eger's work include Cancer Cells and Metastasis (12 papers), Wnt/β-catenin signaling in development and cancer (8 papers) and Cancer-related gene regulation (4 papers). Andreas Eger is often cited by papers focused on Cancer Cells and Metastasis (12 papers), Wnt/β-catenin signaling in development and cancer (8 papers) and Cancer-related gene regulation (4 papers). Andreas Eger collaborates with scholars based in Austria, Germany and Belgium. Andreas Eger's co-authors include Roland Foisner, Hartmut Beug, Thomas Brabletz, Geert Berx, Wolfgang Mikulits, Martin Schreiber, Brigitta Dampier, Mario Mikula, Simone Spaderna and Andreas Jung and has published in prestigious journals such as The Journal of Cell Biology, Gastroenterology and PLoS ONE.

In The Last Decade

Andreas Eger

31 papers receiving 3.5k citations

Hit Papers

DeltaEF1 is a transcriptional repressor of E-cadherin and... 2005 2026 2012 2019 2005 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Eger Austria 23 2.5k 1.6k 927 508 337 31 3.6k
Inna Gitelman Israel 12 2.6k 1.0× 1.9k 1.2× 998 1.1× 417 0.8× 452 1.3× 20 3.9k
Margit A. Huber Germany 13 2.3k 0.9× 1.8k 1.1× 1.2k 1.3× 353 0.7× 329 1.0× 21 3.7k
Christophé Côme Denmark 15 2.9k 1.1× 2.2k 1.4× 1.2k 1.3× 423 0.8× 509 1.5× 25 4.2k
Laura Rosanò Italy 35 2.1k 0.8× 915 0.6× 671 0.7× 418 0.8× 483 1.4× 63 3.7k
Valeriana Di Castro Italy 33 2.0k 0.8× 833 0.5× 641 0.7× 427 0.8× 433 1.3× 56 3.5k
Clara Francı́ Spain 19 3.5k 1.4× 2.2k 1.4× 866 0.9× 570 1.1× 400 1.2× 25 4.7k
Zhenhe Suo Norway 32 1.8k 0.7× 1.3k 0.8× 872 0.9× 290 0.6× 447 1.3× 107 3.1k
Eugene Tulchinsky United Kingdom 31 2.8k 1.1× 1.3k 0.8× 1.1k 1.2× 334 0.7× 403 1.2× 49 3.7k
Dimitris Athineos United Kingdom 26 2.6k 1.0× 1.2k 0.8× 996 1.1× 330 0.6× 212 0.6× 36 3.7k
Chizu Tanikawa Japan 28 1.9k 0.8× 1.2k 0.7× 581 0.6× 289 0.6× 436 1.3× 57 3.1k

Countries citing papers authored by Andreas Eger

Since Specialization
Citations

This map shows the geographic impact of Andreas Eger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Eger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Eger more than expected).

Fields of papers citing papers by Andreas Eger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Eger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Eger. The network helps show where Andreas Eger may publish in the future.

Co-authorship network of co-authors of Andreas Eger

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Eger. A scholar is included among the top collaborators of Andreas Eger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Eger. Andreas Eger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hundsberger, Harald, Elisabeth Hofmann, Maren Pflüger, et al.. (2017). A Screening Approach for Identifying Gliadin Neutralizing Antibodies on Epithelial Intestinal Caco-2 Cells. SLAS DISCOVERY. 22(8). 1035–1043. 8 indexed citations
3.
Hofmann, Elisabeth, Peter Obrist, Christian Klein, et al.. (2016). The combinatorial approach of laser-captured microdissection and reverse transcription quantitative polymerase chain reaction accurately determines HER2 status in breast cancer. Biomarker Research. 4(1). 8–8. 5 indexed citations
5.
Schmid, Johannes A., et al.. (2015). Alpha-Catulin Contributes to Drug-Resistance of Melanoma by Activating NF-κB and AP-1. PLoS ONE. 10(3). e0119402–e0119402. 22 indexed citations
6.
Spilka, Rita, Christina Ernst, Helmut Bergler, et al.. (2014). eIF3a is over-expressed in urinary bladder cancer and influences its phenotype independent of translation initiation. Cellular Oncology. 37(4). 253–267. 43 indexed citations
7.
Bakiri, Latifa, Sabine Macho‐Maschler, J. Niemiec, et al.. (2014). Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression. Cell Death and Differentiation. 22(2). 336–350. 114 indexed citations
8.
Pretsch, Alexander, M. M. Nagl, Miroslav Genov, et al.. (2014). Antimicrobial and Anti-Inflammatory Activities of Endophytic Fungi Talaromyces wortmannii Extracts against Acne-Inducing Bacteria. PLoS ONE. 9(6). e97929–e97929. 42 indexed citations
9.
Hrouzek, Pavel, Marek Kuzma, Simona Bártová, et al.. (2013). Novel Aeruginosin‐865 from Nostoc sp. as a Potent Anti‐inflammatory Agent. ChemBioChem. 14(17). 2329–2337. 30 indexed citations
10.
Imhof, Marianne, et al.. (2012). Interaction of tumor cells with the immune system: implications for dendritic cell therapy and cancer progression. Drug Discovery Today. 18(1-2). 35–42. 6 indexed citations
11.
Maier, Christina, Raphaela Rid, Andrea Trost, et al.. (2012). PIM-1 kinase interacts with the DNA binding domain of the vitamin D receptor: a further kinase implicated in 1,25-(OH)2D3 signaling. BMC Molecular Biology. 13(1). 18–18. 8 indexed citations
12.
Amatschek, Stefan, Rudolf Lucas, Andreas Eger, et al.. (2010). CXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells. British Journal of Cancer. 104(3). 469–479. 56 indexed citations
13.
Spaderna, Simone, Otto Schmalhofer, Mandy Wahlbuhl, et al.. (2008). The Transcriptional Repressor ZEB1 Promotes Metastasis and Loss of Cell Polarity in Cancer. Cancer Research. 68(2). 537–544. 423 indexed citations
14.
Aigner, Karl Reinhard, Brigitta Dampier, Mario Mikula, et al.. (2007). The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene. 26(49). 6979–6988. 492 indexed citations
15.
Spaderna, Simone, Otto Schmalhofer, Falk Hlubek, et al.. (2006). A Transient, EMT-Linked Loss of Basement Membranes Indicates Metastasis and Poor Survival in Colorectal Cancer. Gastroenterology. 131(3). 830–840. 404 indexed citations
16.
Pacher, Margit, Michael J. Seewald, Mario Mikula, et al.. (2006). Impact of constitutive IGF1/IGF2 stimulation on the transcriptional program of human breast cancer cells. Carcinogenesis. 28(1). 49–59. 60 indexed citations
17.
Eger, Andreas, et al.. (2005). Parietal endoderm secreted SPARC promotes early cardiomyogenesis in vitro. Experimental Cell Research. 310(2). 331–343. 33 indexed citations
18.
Gotzmann, Josef, Mario Mikula, Andreas Eger, et al.. (2003). Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. Mutation Research/Reviews in Mutation Research. 566(1). 9–20. 266 indexed citations
19.
Eger, Andreas, et al.. (2001). E-cadherin regulates cell growth by modulating proliferation-dependent β -catenin transcriptional activity. The Journal of Cell Biology. 154(6). 1185–1196. 280 indexed citations
20.
Gotzmann, Josef, Andreas Eger, Rudolf Grimm, et al.. (1997). Two‐dimensional electrophoresis reveals a nuclear matrix‐associated nucleolin complex of basic isoelectric point. Electrophoresis. 18(14). 2645–2653. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026